Risk Treatment

Prove Every Risk Was Treated, Not Just Logged

Plan, assign, and evidence the measures that bring each risk down — Technical and Organizational Measures, owners, and deadlines in one register, with residual risk calculated from what you actually implemented.
For
DPO
ISO
GDPR Art. 32
ISO 27001:2022 Clause 6.1.3
NIS2 Art. 21
The challenge

Treatment actions scatter, and the trail goes cold

Identifying a risk is the easy part. Demonstrating that you treated it — with a named owner, a defined measure, a deadline, and proof of implementation — is where most programs come apart. Treatment actions scatter across spreadsheets, ticketing tools, and email threads, with no single record to pull.

That fragmentation has consequences. You lose sight of which deadlines have slipped, which measures are still "planned" twelve months on, and what your residual risk actually is once controls are in place.

When an auditor or regulator asks "what did you do about this risk, and when?", the answer becomes a reconstruction exercise instead of a record you can produce on demand.

What you can do

What you can do with Risk Treatment Planning

  • Build a treatment plan per asset and standard, with scenario-level actions and a clear owner.
  • Link Technical and Organizational Measures to each scenario and track their implementation status.
  • Set and update deadlines per measure, so slipping and overdue treatments surface instead of going quiet.
  • Track each measure's status — not decided, planned, declined, or implemented — at a glance.
  • Publish plans through an approval step with a full change history of what changed and when.
  • Bulk-update measure statuses across scenarios when a control rollout completes.
Business outcomes

What it delivers to your program

  • Residual risk you can defend — calculated from the measures actually marked implemented, not a manual estimate.
  • No deadline blind spots — overdue treatments surface against their deadlines before they become audit findings.
  • A clean approval baseline — draft versus published states separate work-in-progress from what leadership signed off.
  • Audit answers on demand — the change history shows every treatment decision and date, with no reconstruction scramble.
Built for compliance

Built for compliance

Risk treatment planning supports the documented-mitigation obligations that sit across your privacy and information-security frameworks.

What DPMS doesMaps toHow
Documents the security measures applied to each riskGDPR Art. 32TOMs linked per scenario with implementation status
Plans and tracks risk treatment to closureISO 27001:2022 Clause 6.1.3 / 8.3Treatment plans per asset and standard with owners and deadlines
Evidences security risk-management measuresNIS2 Art. 21Status tracking, deadlines, and publish-time change history
See how this maps to your obligations — book a 30-minute demo.
Book a demo
Why Priverion

Why Priverion

Unlike general-purpose GRC tools, treatment planning here lives inside one unified privacy and InfoSec platform. The same TOMs, assets, and risk scenarios are shared with your risk register, DPIAs, and vendor assessments — so a measure recorded once is reflected wherever it applies, with no re-keying. Residual risk is computed from the measures you actually mark implemented, giving you a number you can stand behind, while draft and published states keep your approval baseline clean.

FAQ

Questions DPOs ask before a demo

How is residual risk calculated?
It's derived from the Technical and Organizational Measures you mark as implemented against each scenario — so the residual figure reflects work actually completed, not a manual guess.
What's the difference between draft and published plans?
Drafts are your working space. Publishing applies an approval step and records a baseline with a change history, so reviewers see exactly what was signed off and what changed since.
Can I see which treatments are overdue?
Each measure carries a deadline you can set and update. Slipping and overdue treatments surface against those deadlines instead of going unnoticed.
Does this connect to the rest of my risk program?
Yes. It shares assets, TOMs, and risk scenarios with the wider DPMS platform, so treatments map back to the risks and standards they address without duplicate entry.

Ready to close out your risk treatments?

See your TOMs, deadlines, and residual risk tracked to closure in one register. Book a 30-minute demo focused on Risk Treatment Planning, or talk to a Priverion expert.
Book a demo